Discovery of Novel Apigenin–Piperazine Hybrids as Potent and Selective Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors for the Treatment of Cancer

Huan Long, Xiaolong Hu, Baolin Wang, Quan Wang, Rong Wang, Shumeng Liu, Fei Xiong, Zhenzhou Jiang, Xiao‐Qi Zhang, Wen‐Cai Ye,

Journal of Medicinal Chemistry · 2021 · 37 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

may serve as a lead compound for chemosensitizers and the (BRCA-1)-deficient cancer therapy.

References

24